Petrelli A et al showed that activation of the nuclear factor erythroid related factor 2 (NRF2) pathway and up-regulation of the miR-200 family were among the most prominent changes of early molecular changes in HCC. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.